1. Home
  2. PAHC vs CIM Comparison

PAHC vs CIM Comparison

Compare PAHC & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$32.07

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Chimera Investment Corporation

CIM

Chimera Investment Corporation

HOLD

Current Price

$13.13

Market Cap

1.1B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAHC
CIM
Founded
1946
2007
Country
United States
United States
Employees
N/A
423
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
PAHC
CIM
Price
$32.07
$13.13
Analyst Decision
Hold
Buy
Analyst Count
4
2
Target Price
$41.25
$15.25
AVG Volume (30 Days)
250.7K
816.0K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
0.91%
10.92%
EPS Growth
1883.33
N/A
EPS
1.90
N/A
Revenue
$833,350,000.00
N/A
Revenue This Year
$17.03
$1.62
Revenue Next Year
$3.82
$2.48
P/E Ratio
$17.04
N/A
Revenue Growth
4.12
N/A
52 Week Low
$25.58
$11.67
52 Week High
$60.08
$14.88

Technical Indicators

Market Signals
Indicator
PAHC
CIM
Relative Strength Index (RSI) 44.94 46.22
Support Level $30.46 $13.05
Resistance Level $34.49 $13.19
Average True Range (ATR) 1.22 0.26
MACD 0.46 -0.03
Stochastic Oscillator 40.30 30.38

Price Performance

Historical Comparison
PAHC
CIM

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About CIM Chimera Investment Corporation

Chimera Investment Corporation is an internally managed REIT whose principal business objective is to provide attractive risk-adjusted returns and distributable income through investment performance linked to mortgage credit fundamentals. Through its mortgage lending, investment management, and advisory services platforms, the Company operates as a fully integrated mortgage business that originates, manages, and invests in a diversified range of mortgage assets. The Company invests, directly or indirectly, generally on a levered basis across a spectrum of mortgage assets, including residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS, MSRs, business purpose and investor loans, including RTLs, and other real estate-related assets.

Share on Social Networks: